首页> 外文期刊>Psychopharmacology >LY2033298, a positive allosteric modulator at muscarinic M 4 receptors, enhances inhibition by oxotremorine of light-induced phase shifts in hamster circadian activity rhythms
【24h】

LY2033298, a positive allosteric modulator at muscarinic M 4 receptors, enhances inhibition by oxotremorine of light-induced phase shifts in hamster circadian activity rhythms

机译:LY2033298是毒蕈碱M 4受体的正变构调节剂,可增强oxotremorine对仓鼠昼夜活动节律中光诱导的相移的抑制作用

获取原文
获取原文并翻译 | 示例
           

摘要

Rationale Entrainment of circadian rhythms to the light-dark cycle is essential for restorative sleep, and abnormal sleep timing is implicated in central nervous system (CNS) disorders like depression, schizophrenia, and Alzheimer's disease. Many transmitters, including acetylcholine, that exerts its actions via muscarinic receptors modulate the suprachiasmatic nucleus, the master pacemaker. Objectives Since positive allosteric modulators of muscarinic M 4 receptors are candidates for treatment of mood and cognitive deficits of CNS disorders, it is important to evaluate their circadian actions. Materials and methods The effects of intraperitoneally applied muscarinic agents on circadian wheel-running rhythms were measured employing hamsters, a model organism for studying activity rhythms. Results Systemic administration of the muscarinic receptor agonist oxotremorine (0.01-0.04 mg/kg) inhibited lightinduced phase delays and advances of hamster circadian wheel-running rhythms. The M 4 positive allosteric modulator, LY 2 0 3 3 2 9 8 (10-40 mg/kg), had no effect on light-induced phase shifts when administered alone, yet significantly enhanced (at 20 mg/kg) the inhibitory influence of oxotremorine on light-induced phase delays. In addition, the muscarinic receptor antagonist, scopolamine, which was without effect on light-induced phase shifts when administered alone (0.001-0.1 mg/kg), antagonized (at 0.1 mg/kg) the inhibitory effect of oxotremorine and LY2033298 on light-induced phase delays. Conclusions These results are the first to demonstrate that systemically applied muscarinic receptor agonists modulate circadian activity rhythms, and they also reveal a specific role for M 4 receptors. It will be of importance to evaluate circadian actions of psychotropic drugs acting via M 4 receptors, since they may display beneficial properties under pathological conditions.
机译:原理将昼夜节律带入明暗循环对于恢复性睡眠至关重要,异常睡眠时间与抑郁,精神分裂症和阿尔茨海默氏病等中枢神经系统(CNS)疾病有关。许多传递器,包括乙酰胆碱,通过毒蕈碱受体发挥其作用,可调节跨步上神经核,即起搏器。目的由于毒蕈碱型M 4受体的正变构调节剂是治疗中枢神经系统疾病的情绪和认知缺陷的候选药物,因此评估其昼夜节律作用很重要。材料和方法使用仓鼠(一种研究活动节奏的模型生物)测量腹膜内施用毒蕈碱剂对昼夜运转的节奏的影响。结果全身施用毒蕈碱受体激动剂oxotremorine(0.01-0.04 mg / kg)抑制了光诱导的相位延迟和仓鼠昼夜运转的节奏。单独使用M 4阳性变构调节剂LY 2 0 3 3 2 9 8(10-40 mg / kg),对光诱导的相移没有影响,但抑制作用显着增强(20 mg / kg)氧吗啡对光诱导的相位延迟的影响。此外,毒蕈碱受体拮抗剂东pol碱(scopolamine)在单独使用时(0.001-0.1 mg / kg)对光诱导的相移没有影响,而在0.1 mg / kg的拮抗作用下拮抗了氧代雷莫林和LY2033298对光的抑制作用。引起的相位延迟。结论这些结果是第一个证明全身应用毒蕈碱受体激动剂可调节昼夜节律活动节律的方法,并且它们还揭示了M 4受体的特定作用。评估经由M 4受体起作用的精神药物的昼夜节律作用将是重要的,因为它们在病理条件下可能显示出有益的特性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号